Division of Pediatric Critical Care, Department of Pediatrics, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Department of Pediatrics, KK Women's and Children's Hospital, Singapore.
Pediatr Crit Care Med. 2021 Aug 1;22(8):713-721. doi: 10.1097/PCC.0000000000002680.
Pediatric sepsis remains a major health problem and is a leading cause of death and long-term disability worldwide. This study aims to characterize epidemiologic, therapeutic, and outcome features of pediatric severe sepsis and septic shock in three Asian countries.
A multicenter retrospective study with longitudinal clinical data over 1, 6, 24, 48, and 72 hours of PICU admission. The primary outcome was PICU mortality. Multivariable logistic regression analysis was used to identify factors at PICU admission that were associated with mortality.
Nine multidisciplinary PICUs in three Asian countries.
Children with severe sepsis or septic shock admitted to the PICU from January to December 2017.
None.
A total of 271 children were included in this study. Median (interquartile range) age was 4.2 years (1.3-10.8 yr). Pneumonia (77/271 [28.4%]) was the most common source of infection. Majority of patients (243/271 [90%]) were resuscitated within the first hour, with fluid bolus (199/271 [73.4%]) or vasopressors (162/271 [59.8%]). Fluid resuscitation commonly took the form of normal saline (147/199 [74.2%]) (20 mL/kg [10-20 mL/kg] over 20 min [15-30 min]). The most common inotrope used was norepinephrine 81 of 162 (50.0%). Overall PICU mortality was 52 of 271 (19.2%). Improved hemodynamic variables (e.g., heart rate, blood pressure, and arterial lactate) were seen in survivors within 6 hours of admission as compared to nonsurvivors. In the multivariable model, admission severity score was associated with PICU mortality.
Mortality from pediatric severe sepsis and septic shock remains high in Asia. Consistent with current guidelines, most of the children admitted to these PICUs received fluid therapy and inotropic support as recommended.
儿科脓毒症仍然是一个主要的健康问题,也是全球范围内导致死亡和长期残疾的主要原因。本研究旨在描述三个亚洲国家儿科严重脓毒症和脓毒性休克的流行病学、治疗和结局特征。
一项多中心回顾性研究,具有纵向临床数据,包括 PICU 入院后 1、6、24、48 和 72 小时。主要结局是 PICU 死亡率。采用多变量逻辑回归分析确定 PICU 入院时与死亡率相关的因素。
三个亚洲国家的 9 个多学科 PICU。
2017 年 1 月至 12 月期间收入 PICU 的患有严重脓毒症或脓毒性休克的儿童。
无。
本研究共纳入 271 名儿童。中位(四分位距)年龄为 4.2 岁(1.3-10.8 岁)。肺炎(77/271 [28.4%])是最常见的感染源。大多数患者(243/271 [90%])在第一个小时内接受复苏治疗,使用液体冲击(199/271 [73.4%])或血管加压素(162/271 [59.8%])。液体复苏通常采用生理盐水(147/199 [74.2%])(20 mL/kg [10-20 mL/kg],20 分钟[15-30 分钟])。最常用的儿茶酚胺类药物是去甲肾上腺素 81 例/162 例(50.0%)。总体而言,271 例儿童中,PICU 死亡率为 52/271(19.2%)。与幸存者相比,入院后 6 小时内,存活者的血流动力学变量(如心率、血压和动脉乳酸)得到改善。在多变量模型中,入院严重程度评分与 PICU 死亡率相关。
亚洲地区儿科严重脓毒症和脓毒性休克的死亡率仍然很高。与目前的指南一致,大多数收入这些 PICU 的儿童接受了推荐的液体治疗和正性肌力支持。